HealthpointCapital

HealthpointCapital is a New York-based private equity firm with a long track record of investing in Israeli medtech, focused exclusively on orthopedic, musculoskeletal, and surgical device innovations. As a PE rather than venture firm, it operates at a later stage with larger checks and expects companies to have meaningful commercial traction or clear paths to scale. Founders should treat this as a growth-stage option rather than an early or even early-growth backer.

The stage listed is Growth, with check sizes of $25 million and above. The sole sub-vertical is medical devices. While the record does not list portfolio companies, the firm’s specialization in orthopedics and musculoskeletal devices means founders working outside that anatomical and procedural space will find limited fit. Geographic activity covers United States and Israeli medtech.

Approach HealthpointCapital when the company has revenue, regulatory clearances, and a credible path to category leadership in orthopedic, spine, sports medicine, joint replacement, or related surgical device categories. Healthcare AI founders should consider HealthpointCapital only if the AI is embedded in an orthopedic or musculoskeletal device or surgical workflow with clear procedural codes and reimbursement paths. Pure software, clinical decision support without device integration, or unrelated specialty products are unlikely to fit. Expect detailed commercial diligence and longer hold periods consistent with PE rather than VC behavior.